Ara
Toplam kayıt 1, listelenen: 1-1
Reduction in First and Recurrent Cardiovascular Events with Ticagrelor Compared with Clopidogrel in the Plato Study
(Lippincott Williams & Wilkins, 2013)
Background-We sought to evaluate the effect of potent platelet inhibition after acute coronary syndrome on total (ie, first and recurrent) occurrences of any of the primary outcome events (eg, cardiovascular death, myocardial ...